Literature DB >> 11389610

Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.

O Boutaud1, C J Brame, P Chaurand, J Li, S W Rowlinson, B C Crews, C Ji, L J Marnett, R M Caprioli, L J Roberts, J A Oates.   

Abstract

These investigations characterize the covalent binding of reactive products of prostaglandin H-synthases (PGHSs) to the enzyme and to other molecules. The intermediate product of oxygenation of arachidonic acid by the PGHSs, prostaglandin (PG) H2, undergoes rearrangement to the highly reactive gamma-keto aldehydes, levuglandin (LG) E2 and D2. We previously have demonstrated that LGE2 reacts with the epsilon-amine of lysine to form both the lysyl-levuglandin Shiff base and the pyrrole-derived lysyl-levuglandin lactam adducts. We now demonstrate that these lysyl-levuglandin adducts are formed on the PGHSs following the oxygenation of arachidonic acid; after reduction of the putative Schiff base, proteolytic digestion of the enzyme, and isolation of the adducted amino acid residues, these adducts were identified by liquid chromatography-tandem mass spectrometry. The reactivity of the LGs is reflected by the finding that virtually all of the LG predicted to be formed from PGH2 can be accounted for as adducts of the PGH-synthase and that oxygenation of arachidonic acid by PGH-synthases also leads to the formation of adducts of other proteins present in the reaction solution. The reactivity of the PGH-synthase adducts themselves is demonstrated by the formation of intermolecular cross-links.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389610     DOI: 10.1021/bi002629k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

2.  PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Authors:  Olivier Boutaud; Thomas J Montine; Lei Chang; William L Klein; John A Oates
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

3.  Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

Authors:  Sean S Davies; Eric J Brantley; Paul A Voziyan; Venkataraman Amarnath; Irene Zagol-Ikapitte; Olivier Boutaud; Billy G Hudson; John A Oates; L Jackson Roberts
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

4.  Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studies.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Satyawan Jadhav; John A Oates; Olivier Boutaud
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-21       Impact factor: 3.205

5.  Molecular Structures of Isolevuglandin-Protein Cross-Links.

Authors:  Wenzhao Bi; Geeng-Fu Jang; Lei Zhang; John W Crabb; James Laird; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

Review 6.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

7.  Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.

Authors:  Erica J Carrier; Venkataraman Amarnath; John A Oates; Olivier Boutaud
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

8.  Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.

Authors:  Anna Dikalova; Vladimir Mayorov; Liang Xiao; Alexander Panov; Venkataraman Amarnath; Irene Zagol-Ikapitte; Aurelia Vergeade; Mingfang Ao; Valery Yermalitsky; Rafal R Nazarewicz; Olivier Boutaud; Marcos G Lopez; Frederic T Billings; Sean Davies; L Jackson Roberts; David G Harrison; Sergey Dikalov
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

Review 9.  Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.

Authors:  Sean S Davies; Linda S May-Zhang; Olivier Boutaud; Venkataraman Amarnath; Annet Kirabo; David G Harrison
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

10.  Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis.

Authors:  Olivier Boutaud; I Romina Sosa; Taneem Amin; Denise Oram; David Adler; Hyun S Hwang; Brenda C Crews; Ginger Milne; Bradford K Harris; Megan Hoeksema; Bjorn C Knollmann; Philip E Lammers; Lawrence J Marnett; Pierre P Massion; John A Oates
Journal:  Cancer Prev Res (Phila)       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.